ProCE Banner Activity

Long-Acting Injectable ART: What Do Patients Think?

Conference Coverage
Clinical Thought
Patient-reported outcomes on long-acting injectable cabotegravir plus rilpivirine reinforce high treatment acceptance and satisfaction. Here’s my take on what this means for patients and practice.

Released: September 12, 2019

Share

Provided by

Provided by the USF Health
ProCE Banner

Supporters

Educational grant provided by:

Gilead

ViiV Healthcare

Partners

IAS 2018

ProCE Banner

IAS 2019

ProCE Banner